Researchers from the Tufts Center for the Study of Drug Development report that taking a new drug from discovery to market approval requires about $2.6 billion, more than twice what it cost in 2003. They based their estimate on data provided by 10 pharmaceutical companies on 106 randomly chosen drugs, including 19 anticancer agents.
No takes yet. Share an insight, caveat, or question.
A 2014 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: